Meta-analysis from 19 eligible studies included a total of 5,926 patients with a median number of 312 patients per study failed to recognize that caveolin-1 expression in tumor cells as a predictive marker for breast cancer prognosis. This evidence concerns the gene CAV1 and neoplasm.